Ratings coverage on AutoNavi Holdings Ltd (NASDAQ: AMAP), Hill-Rom Holdings, Inc. (NYSE: HRC), Oncolytics Biotech, Inc. (NASDAQ: ONCY), Thoratec (NASDAQ: THOR) and CVR Partners (NYSE: UAN) was initiated by analysts recently.
Deutsche Bank (NYSE:DB) initiated coverage on AutoNavi Holdings Ltd (AMAP). They placed a “buy” rating and a price target of $22.00 on the company.
Goldman Sachs (NYSE:GS) initiated coverage on Hill-Rom Holdings, Inc. (HRC). They placed a “neutral” rating on the company.
Oppenheimer initiated coverage on Oncolytics Biotech, Inc. (NASDAQ: ONCY). They placed a “perform” rating on the company.
Oppenheimer initiated coverage on Thoratec (NASDAQ: THOR). They placed an “outperform” rating and a price target of $40.00 on the company.
Morgan Stanley (NYSE:MS) initiated coverage on CVR Partners (NYSE: UAN). They placed an “equal weight” rating on the company.
Saturday, May 21, 2011
Ratings (AMAP) (HRC) (ONCY) (THOR) (UAN) Weekend Recap
Wednesday, May 18, 2011
Coverage on (ONCY) (OPTR) (SD) (PMCS) (POT) Initiated
Coverage on Oncolytics Biotech, Inc. (NASDAQ: ONCY), Optimer Pharmaceutic (NASDAQ: OPTR), SandRidge Energy Inc. (NYSE: SD), PMC-Sierra, Inc. (NASDAQ: PMCS) and Potash Corp (NYSE: POT) was initiated by analysts.
Robert W. Baird initiated coverage on SandRidge Energy Inc. (SD). They placed a “neutral” rating and a price target of $12.00 on the company.
Oppenheimer analysts initiated coverage on Oncolytics Biotech, Inc. (ONCY). They placed a “perform” rating on the company.
ThinkEquity initiated coverage on Optimer Pharmaceutic (OPTR). They placed a “buy” rating and a price target of $18.00 on the company.
Auriga initiated coverage on PMC-Sierra, Inc. (PMCS). They placed a “hold” rating and a price target of $8.00 on the company.
Macquarie initiated coverage on Potash Corp (POT). They placed an “outperform” rating and a price target of $62.00 on the company.
Tuesday, May 17, 2011
Coverage on (ONCY) (OPTR) (SD) (PMCS) (POT) Initiated
Coverage on Oncolytics Biotech, Inc. (NASDAQ: ONCY), Optimer Pharmaceutic (NASDAQ: OPTR), SandRidge Energy Inc. (NYSE: SD), PMC-Sierra, Inc. (NASDAQ: PMCS) and Potash Corp (NYSE: POT) was initiated by analysts.
Robert W. Baird initiated coverage on SandRidge Energy Inc. (SD). They placed a “neutral” rating and a price target of $12.00 on the company.
Oppenheimer analysts initiated coverage on Oncolytics Biotech, Inc. (ONCY). They placed a “perform” rating on the company.
ThinkEquity initiated coverage on Optimer Pharmaceutic (OPTR). They placed a “buy” rating and a price target of $18.00 on the company.
Auriga initiated coverage on PMC-Sierra, Inc. (PMCS). They placed a “hold” rating and a price target of $8.00 on the company.
Macquarie initiated coverage on Potash Corp (POT). They placed an “outperform” rating and a price target of $62.00 on the company.